We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2579:TSECoca-Cola Bottlers Japan Holdings Inc. Analysis

Data as of 2026-06-04 - not real-time

HK$32.88

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

CNGR Advanced Material is trading at HK$32.88, well below its 20‑day (HK$36.38) and 50‑day (HK$37.08) moving averages, with a 14‑day RSI of 35.6 and a bearish MACD histogram, indicating short‑term weakness. Volume has been slipping, and 30‑day volatility is unusually high at 64%, though the stock’s beta of 0.16 suggests limited market‑wide risk. On the fundamentals side, the company carries a heavy debt load (Debt/Equity ≈ 89%) and negative free cash flow, while ROE is modest at 6.5%. The DCF‑derived fair value of HK$12.29 is far below the current price, flagging the stock as potentially overvalued despite a forward PE of 11.5 and a modest dividend yield of 1.31% that may not be sustainable.
The battery‑materials niche offers long‑term secular growth, and the firm’s global footprint mitigates some geographic concentration, but the combination of high leverage, cash‑flow strain, and technical downside pressure suggests a cautious stance. Investors should weigh the upside from industry tailwinds against the near‑term valuation gap and liquidity constraints.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below key moving averages
  • Bearish MACD and low RSI
  • Decreasing volume and high short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Forward earnings improvement (forward PE 11.5)
  • Secular demand for battery materials
  • High debt and negative free cash flow limiting upside

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Industry tailwinds in EV and energy‑storage markets
  • Diversified geographic exposure
  • Financial constraints (leverage, cash‑flow) tempering valuation appeal

Key Metrics & Analysis

Financial Health

Revenue Growth46.00%
Profit Margin3.42%
P/E Ratio15.4
ROE6.46%
ROA3.00%
Debt/Equity89.08
P/B Ratio1.2
Op. Cash FlowHK$1.3B
Free Cash FlowHK$-4562525184

Technical Analysis

TrendNeutral
RSI35.6
SupportHK$32.50
ResistanceHK$44.52
MA 20HK$36.38
MA 50HK$37.08
MA 200HK$34.58
MACDBearish
VolumeDecreasing
Fear & Greed Index92.75

Valuation

Fair ValueHK$12.29
Target PriceHK$49.50
Upside/Downside50.55%
GradeOvervalued
TypeBlend
Dividend Yield1.31%

Risk Assessment

Beta0.16
Volatility64.38%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.